Molnupiravir: Is It Time to Move In or Move Out?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38319185.
- Also identified by DOI 10.1056/EVIDe2100048.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Molnupiravir: Is It Time to Move In or Move Out?With more than 250 million diagnosed cases and 5 million deaths, Covid-19 is our epoch-defining pandemic - and it is still ongoing. Despite the development of several effective Covid-19 vaccines, there are a limited number of antiviral treatments to reduce disease progression, risk of hospitalization, and death once the infection occurs. In this editorial, we examine the results of the phase 2 randomized, placebo-controlled, double-blind trials evaluating the safety and efficacy of molnupiravir, ...